Artal Group as of June 30, 2016
Portfolio Holdings for Artal Group
Artal Group holds 60 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 55.4 | $2.7B | 115M | 23.34 | |
| Lexicon Pharmaceuticals (LXRX) | 17.0 | $825M | 58M | 14.35 | |
| Weight Watchers International | 7.1 | $342M | 29M | 11.63 | |
| Goldman Sachs (GS) | 4.5 | $215M | 1.5M | 148.58 | |
| Bank of America Corporation (BAC) | 1.7 | $81M | 6.1M | 13.27 | |
| Regeneron Pharmaceuticals (REGN) | 1.2 | $59M | 170k | 349.24 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $56M | 1.0M | 55.49 | |
| Incyte Corporation (INCY) | 1.0 | $50M | 625k | 79.98 | |
| Wal-Mart Stores (WMT) | 0.8 | $37M | 500k | 73.02 | |
| Biogen Idec (BIIB) | 0.8 | $36M | 150k | 241.82 | |
| Alibaba Group Holding (BABA) | 0.7 | $32M | 400k | 79.53 | |
| MetLife (MET) | 0.6 | $30M | 750k | 39.83 | |
| Alphabet Inc Class A cs (GOOGL) | 0.6 | $28M | 40k | 703.52 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $27M | 350k | 77.80 | |
| Bluebird Bio | 0.5 | $24M | 550k | 43.29 | |
| Celgene Corporation | 0.4 | $20M | 200k | 98.63 | |
| Nektar Therapeutics | 0.4 | $20M | 1.4M | 14.23 | |
| Delphi Automotive | 0.4 | $17M | 275k | 62.60 | |
| Kite Pharma | 0.3 | $16M | 325k | 50.00 | |
| Tesla Motors (TSLA) | 0.3 | $16M | 75k | 212.28 | |
| JPMorgan Chase & Co. (JPM) | 0.3 | $16M | 250k | 62.14 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $16M | 375k | 41.90 | |
| International Business Machines (IBM) | 0.3 | $15M | 100k | 151.78 | |
| Array BioPharma | 0.3 | $14M | 3.9M | 3.56 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $13M | 150k | 86.02 | |
| Us Foods Hldg Corp call (USFD) | 0.2 | $12M | 500k | 24.24 | |
| Citigroup (C) | 0.2 | $11M | 250k | 42.39 | |
| Morgan Stanley (MS) | 0.2 | $10M | 400k | 25.98 | |
| Juno Therapeutics | 0.2 | $9.6M | 250k | 38.44 | |
| Seres Therapeutics | 0.2 | $9.0M | 310k | 29.05 | |
| Radius Health | 0.1 | $7.4M | 200k | 36.75 | |
| Amicus Therapeutics (FOLD) | 0.1 | $6.8M | 1.3M | 5.46 | |
| Spectranetics Corporation | 0.1 | $6.5M | 350k | 18.71 | |
| Agenus | 0.1 | $6.1M | 1.5M | 4.05 | |
| Avexis | 0.1 | $6.2M | 162k | 38.02 | |
| Horizon Pharma | 0.1 | $5.8M | 350k | 16.47 | |
| Cellectis S A (CLLS) | 0.1 | $5.6M | 210k | 26.59 | |
| Jd (JD) | 0.1 | $5.3M | 250k | 21.23 | |
| Intellia Therapeutics (NTLA) | 0.1 | $4.8M | 225k | 21.35 | |
| Neurocrine Biosciences (NBIX) | 0.1 | $4.3M | 95k | 45.45 | |
| Chemocentryx | 0.1 | $4.0M | 900k | 4.49 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $3.7M | 75k | 48.91 | |
| Ignyta | 0.1 | $4.1M | 750k | 5.42 | |
| BioTime | 0.1 | $3.3M | 1.3M | 2.61 | |
| Acceleron Pharma | 0.1 | $3.4M | 100k | 33.98 | |
| Celldex Therapeutics | 0.1 | $3.0M | 675k | 4.39 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.8M | 217k | 13.08 | |
| Sage Therapeutics (SAGE) | 0.1 | $3.0M | 100k | 30.13 | |
| Ophthotech | 0.1 | $2.6M | 50k | 51.04 | |
| Spark Therapeutics | 0.1 | $2.6M | 50k | 51.14 | |
| Sarepta Therapeutics (SRPT) | 0.0 | $1.9M | 100k | 19.07 | |
| Global Blood Therapeutics In | 0.0 | $2.1M | 125k | 16.59 | |
| Aegerion Pharmaceuticals | 0.0 | $1.5M | 1.0M | 1.49 | |
| Cempra | 0.0 | $1.6M | 100k | 16.49 | |
| Nantkwest | 0.0 | $1.4M | 225k | 6.22 | |
| Regenxbio Inc equity us cm (RGNX) | 0.0 | $1.6M | 200k | 8.00 | |
| Dimension Therapeutics | 0.0 | $1.7M | 275k | 6.00 | |
| Ceres | 0.0 | $399k | 1.0M | 0.39 | |
| Colucid Pharmaceuticals | 0.0 | $46k | 5.6k | 8.25 | |
| Oncocyte | 0.0 | $228k | 64k | 3.56 |
